|
... we need to see a shift from D2C apps to integrated, reimbursable solutions in mainstream health ... Key findings: Gynaecology and oncology account for more than half of Femtech ventures Health system ...
01Net
-
9-6-2025
|
|
|
|
Mithridates Therapeutics optimizes bio - active molecules from venom and animal toxins to develop innovative peptide therapeutics for medical solutions. RedPoint Oncology precision oncology, ...
01Net
-
2-6-2025
|
|
|
|
... the expanded capabilities of Tempus One offer physicians in oncology and beyond more support in ... collaborating with them to create and test custom GenAI solutions tailored to their unique needs and ...
01Net
-
1-6-2025
|
|
|
|
... Tempus provides AI - enabled precision medicine solutions to physicians to deliver personalized ... but not limited to, statements regarding the potential impact of Fuses and its insights in oncology ...
01Net
-
31-5-2025
|
|
|
|
On May 30 th , ConcertAI announced its oncology Precision Suite of generative and agentic AI solutions for advancing analytics and inferences, and for clinical trial design and optimization. The ...
01Net
-
31-5-2025
|
|
|
|
... neurology and oncology, with an innovative pipeline, all aimed at enabling better informed ... GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical ...
01Net
-
30-5-2025
|
|
|
|
... the leader in generating personalized real - world evidence (RWE) from real - world clinical data, today announced key personnel and product features enhancing their Oncology solutions. The company ...
01Net
-
30-5-2025
|
|
|
|
Tempus will present its cutting - edge clinical findings and innovative technologies, highlighting the company's use of AI - driven solutions to advance precision oncology. "At ASCO 2025, we are ...
01Net
-
30-5-2025
|
|
|
|
- - (BUSINESS WIRE) - - ConcertAI , a leader in oncology - focused generative and agentic AI solutions, today announced the launch of its new Precision Suite. This groundbreaking family of AI - ...
01Net
-
30-5-2025
|
|
|
|
CHICAGO - - (BUSINESS WIRE) - - Onc. AI, a digital health company developing AI - powered oncology clinical management solutions, today announced that new validation study results from research collaborations with Pfizer, Baylor Scott & White and the University of Rochester Medical Center ...
01Net
-
30-5-2025
|
|
|
